| Biodegradable injectable in situ forming drug delivery systems A Hatefi, B Amsden Journal of controlled release 80 (1-3), 9-28, 2002 | 976 | 2002 |
| Camptothecin delivery methods A Hatefi, B Amsden Pharmaceutical research 19, 1389-1399, 2002 | 221 | 2002 |
| Progress and problems with the use of suicide genes for targeted cancer therapy Z Karjoo, X Chen, A Hatefi Advanced drug delivery reviews 99, 113-128, 2016 | 206 | 2016 |
| Gene transfer efficiency of high primary amine content, hydrophobic, alkyl-oligoamine derivatives of polyethylenimine A Dehshahri, RK Oskuee, WT Shier, A Hatefi, M Ramezani Biomaterials 30 (25), 4187-4194, 2009 | 119 | 2009 |
| Enzyme/prodrug systems for cancer gene therapy OM Malekshah, X Chen, A Nomani, S Sarkar, A Hatefi Current pharmacology reports 2, 299-308, 2016 | 84 | 2016 |
| Adenoviral gene delivery to solid tumors by recombinant silk–elastinlike protein polymers A Hatefi, J Cappello, H Ghandehari Pharmaceutical research 24, 773-779, 2007 | 79 | 2007 |
| Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme/prodrug systems FS Nouri, X Wang, A Hatefi Journal of Controlled Release 200, 179-187, 2015 | 73 | 2015 |
| Development of recombinant cationic polymers for gene therapy research BF Canine, A Hatefi Advanced drug delivery reviews 62 (15), 1524-1529, 2010 | 72 | 2010 |
| A designer biomimetic vector with a chimeric architecture for targeted gene transfer Y Wang, SS Mangipudi, BF Canine, A Hatefi Journal of controlled release 137 (1), 46-53, 2009 | 66 | 2009 |
| Recombinant polymer‐protein fusion: a promising approach towards efficient and targeted gene delivery A Hatefi, Z Megeed, H Ghandehari The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2006 | 65 | 2006 |
| Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells BF Canine, Y Wang, A Hatefi Journal of Controlled Release 138 (3), 188-196, 2009 | 61 | 2009 |
| HSV-TK/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector Y Wang, BF Canine, A Hatefi Nanomedicine: Nanotechnology, Biology and Medicine 7 (2), 193-200, 2011 | 52 | 2011 |
| Modified polyethyleneimine with histidine–lysine short peptides as gene carrier M Hashemi, BH Parhiz, A Hatefi, M Ramezani Cancer gene therapy 18 (1), 12-19, 2011 | 51 | 2011 |
| A recombinant biopolymeric platform for reliable evaluation of the activity of pH-responsive amphiphile fusogenic peptides FS Nouri, X Wang, M Dorrani, Z Karjoo, A Hatefi Biomacromolecules 14 (6), 2033-2040, 2013 | 49 | 2013 |
| Perspectives in vector development for systemic cancer gene therapy A Hatefi, BF Canine Gene therapy & molecular biology 13 (A), 15, 2009 | 49 | 2009 |
| Development of a genetically engineered biomimetic vector for targeted gene transfer to breast cancer cells SS Mangipudi, BF Canine, Y Wang, A Hatefi Molecular pharmaceutics 6 (4), 1100-1109, 2009 | 48 | 2009 |
| Recombinant polymers for cancer gene therapy: a minireview M Haider, A Hatefi, H Ghandehari Journal of controlled release 109 (1-3), 108-119, 2005 | 48 | 2005 |
| Design, engineering and preparation of a multi-domain fusion vector for gene delivery F Sadeghian, S Hosseinkhani, A Alizadeh, A Hatefi International journal of pharmaceutics 427 (2), 393-399, 2012 | 45 | 2012 |
| Evaluation of the effect of vector architecture on DNA condensation and gene transfer efficiency BF Canine, Y Wang, A Hatefi Journal of controlled release 129 (2), 117-123, 2008 | 43 | 2008 |
| Advances with the use of bio-inspired vectors towards creation of artificial viruses HO McCarthy, Y Wang, SS Mangipudi, A Hatefi Expert opinion on drug delivery 7 (4), 497-512, 2010 | 42 | 2010 |
